SIM
AKCA

Sonora Investment Management’s Akcea Therapeutics Inc AKCA Stock Holding History

Sonora Investment Management’s Portfolio AKCA Stock Details AKCA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-50
Closed -$1K – 1825
2020
Q3 		$1K Hold
50
– – ﹤0.01% 1751
2020
Q2 		$1K Hold
50
– – ﹤0.01% 1725
2020
Q1 		$1K Hold
50
– – ﹤0.01% 1645
2019
Q4 		$1K Hold
50
– – ﹤0.01% 1648
2019
Q3 		$1K Hold
50
– – ﹤0.01% 1638
2019
Q2 		$1K Hold
50
– – ﹤0.01% 1646
2019
Q1 		$1K Hold
50
– – ﹤0.01% 1458
2018
Q4 		$2K Hold
50
– – ﹤0.01% 1162
2018
Q3 		$2K Hold
50
– – ﹤0.01% 1134
2018
Q2 		$1K Hold
50
– – ﹤0.01% 1137
2018
Q1 		$1.28K Hold
50
– – ﹤0.01% 1101
2017
Q4 		$868 Hold
50
– – ﹤0.01% 1135
2017
Q3 		$1.38K Buy
+50
New +$926 ﹤0.01% 1030

Sonora Investment Management's AKCA Position: Q4 2020 in Review

Sonora Investment Management sold out of Akcea Therapeutics Inc (AKCA) in Q4 2020, closing a stake of 50 shares — an estimated $1K sold.

Sonora Investment Management first reported a position in AKCA in Q3 2017 and held it in 13 quarters. The position peaked at $2K in Q4 2018. 0 funds tracked by Wall St. Rank hold AKCA as of Q4 2020.

  • Sonora Investment Management reported no remaining Akcea Therapeutics Inc position as of Q4 2020 after selling out during the quarter.
  • Sonora Investment Management sold 50 Akcea Therapeutics Inc shares in Q4 2020, an estimated $1K.
  • Sonora Investment Management first reported a position in Akcea Therapeutics Inc in Q3 2017 and held it in 13 quarters.
  • Sonora Investment Management's Akcea Therapeutics Inc position peaked at $2K in Q4 2018.
  • 0 funds tracked by Wall St. Rank held Akcea Therapeutics Inc as of Q4 2020.

Based on Sonora Investment Management's 13F filing for Q4 2020, filed 13 Jan 2021.